2019 Multi-Drug Efflux Systems GRC/GRS
2019 Multi-Drug Efflux Systems GRC/GRS
批准号:
9760371
负责人:
Deanna L Kroetz
金额:
$0.75万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-02-06 至 2019-05-31
关键词:
AcademiaAddressAffectBasic ScienceBiochemicalBiological AssayBiologyBiophysicsBiotechnologyCareer ChoiceChemicalsClimateClinicalClinical PharmacologyCollaborationsCommunicable DiseasesComputer AnalysisCryoelectron MicroscopyDataDevelopmentDisciplineDrug EffluxDrug KineticsDrug TargetingDrug resistanceEnsureEnvironmentFosteringFutureGenomicsGoalsGrantHealthHourHumanIndustryInfectionInfectious AgentInternationalInterventionItalyKnowledgeLearningLung diseasesMalariaMalignant NeoplasmsMedicineMentorshipMethodsMicrobiologyMinorityModernizationMolecularMulti-Drug ResistanceNatureOralParticipantPharmacodynamicsPharmacologic SubstancePharmacologyPharmacotherapyPostdoctoral FellowPropertyPumpRequest for ProposalsResearchResearch PersonnelResistanceScienceScientific Advances and AccomplishmentsScientistSenior ScientistSignaling MoleculeSystemTimeToxic effectTranslatingTranslational ResearchTuberculosisUnderrepresented MinorityWomanWritingcareercollaborative environmentdesigndiarrheal diseasedrug discoverydrug resistant pathogenefflux pumpglobal healthgraduate studentimprovedinhibitor/antagonistinnovationmembrane reconstitutionmetabolomicsmicroorganismnew therapeutic targetnovelnovel strategiesnovel therapeutic interventionorgan on a chippeerposterspreventsmall molecule therapeuticssuccesssupportive environmentsymposiumsystems researchtherapeutic developmenttoolunpublished works
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
The modern era of discovery and clinical use of small molecule therapeutics to treat infectious diseases is
threatened by rapidly spreading drug resistance. Drug resistance affects all major groups of infectious
diseases but is particularly troubling among causative agents of such devastating infections as diarrheal and
respiratory diseases, malaria and tuberculosis. Concerted efforts among basic, translational and drug
discovery researchers are urgently needed to prevent further spread of resistance and to develop effective
approaches to anticipate and to counter present and future drug resistant pathogens. This proposal requests
partial support for the Gordon Research Conference (GRC) and Gordon Research Seminar (GRS) on
Multidrug Efflux Systems to be held in Barga, Italy, April 27-May 3, 2019. This conference will fill a major gap in
addressing critical issues and novel approaches to achieve the goals of effective reversal of persistent
multidrug resistance worldwide and the development of therapeutics with optimal efficacy and reduced toxicity.
The goal of this conference and seminar is to provide a stimulating and collaborative environment for
researchers to openly discuss unpublished work, push the boundaries of science, and foster scientific
interactions between young investigators, leaders in the field, and colleagues working in academia and the
pharmaceutical/biotechnology industry. A major goal is to bring together researchers with expertise in diverse
disciplines who traditionally have limited interaction to share progress and engage in discussion of challenges
and opportunities in the field. The participation of researchers studying multidrug resistance pumps in
microorganisms and those studying mammalian efflux pumps is designed to introduce technological advances
and transformative approaches to each field. The goals of this GRC will be accomplished by the internationally
recognized keynote speakers, the eight scientific sessions with over 30 invited speakers and additional
discussion leaders, and the unique format and setting that facilitates fruitful interactions between participants at
all career stages. Speakers in each session will present cutting-edge, unpublished data and innovative ideas
on issues that are critical to the success of targeting multidrug efflux pumps for the reversal of resistance. The
interactive nature of the GRC scientific and poster sessions and the participation of researchers from diverse
research sectors is an optimal forum for graduate students and postdoctoral fellows to expand their scientific
breadth, interact with leaders in the field, establish future collaborative relationships and consider various
career paths. Submitted abstracts from trainees and underrepresented minorities will be targeted for oral
presentations in each session. Through participation in the GRS prior to the main conference, trainees will
have additional opportunities for oral and poster presentations and to develop relationships with their peers in a
nurturing environment. The 2019 GRC and GRS on Multidrug Efflux Systems will further stimulate cutting-edge
basic and translational research on the important biomedical problem of multidrug resistance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Sphingolipid Signaling and Chemotherapy-Induced Peripheral Neurotoxicity
-
批准号:10643811
-
项目类别:
-
资助金额:$15.46万
-
财政年份:2021
-
负责人:Deanna L Kroetz
-
依托单位:
Contribution of Nuclear S1P Signaling to Microtubule Targeting Agent-Induced Changes in Transcriptional Activity in Human iPS-SNs
-
批准号:10599009
-
项目类别:
-
资助金额:$6.2万
-
财政年份:2021
-
负责人:Deanna L Kroetz
-
依托单位:
Sphingolipid Signaling and Chemotherapy-Induced Peripheral Neurotoxicity
-
批准号:10947162
-
项目类别:
-
资助金额:$39.68万
-
财政年份:2021
-
负责人:Deanna L Kroetz
-
依托单位:
Sphingolipid Signaling and Chemotherapy-Induced Peripheral Neurotoxicity
-
批准号:10230429
-
项目类别:
-
资助金额:$57.1万
-
财政年份:2021
-
负责人:Deanna L Kroetz
-
依托单位:
Sphingolipid Signaling and Chemotherapy-Induced Peripheral Neurotoxicity
-
批准号:10737832
-
项目类别:
-
资助金额:$7.21万
-
财政年份:2021
-
负责人:Deanna L Kroetz
-
依托单位:
Sphingolipid Signaling and Chemotherapy-Induced Peripheral Neurotoxicity
-
批准号:10373099
-
项目类别:
-
资助金额:$56.29万
-
财政年份:2021
-
负责人:Deanna L Kroetz
-
依托单位:
Mechanisms of Renoprotection by Soluble Epoxide Hydrolase Inhibition
-
批准号:8539676
-
项目类别:
-
资助金额:$36.18万
-
财政年份:2010
-
负责人:Deanna L Kroetz
-
依托单位:
Mechanisms of Renoprotection by Soluble Epoxide Hydrolase Inhibition
-
批准号:8325925
-
项目类别:
-
资助金额:$36.88万
-
财政年份:2010
-
负责人:Deanna L Kroetz
-
依托单位:
Mechanisms of Renoprotection by Soluble Epoxide Hydrolase Inhibition
-
批准号:7885244
-
项目类别:
-
资助金额:$46.42万
-
财政年份:2010
-
负责人:Deanna L Kroetz
-
依托单位:
Mechanisms of Renoprotection by Soluble Epoxide Hydrolase Inhibition
-
批准号:8118786
-
项目类别:
-
资助金额:$37.12万
-
财政年份:2010
-
负责人:Deanna L Kroetz
-
依托单位:
Mechanisms of Renoprotection by Soluble Epoxide Hydrolase Inhibition
-
批准号:8730133
-
项目类别:
-
资助金额:$37.39万
-
财政年份:2010
-
负责人:Deanna L Kroetz
-
依托单位:
DIGOXIN TWIN STUDY
-
批准号:7202617
-
项目类别:
-
资助金额:$1.31万
-
财政年份:2005
-
负责人:Deanna L Kroetz
-
依托单位:
Impact of Genetics on Digoxin Pharmacokinetics
-
批准号:6972264
-
项目类别:
-
资助金额:$1.58万
-
财政年份:2004
-
负责人:Deanna L Kroetz
-
依托单位:
PHARMACOLOGICAL EFFECTS OF CYTOCHROME P450 4A METABOLISM
-
批准号:2750459
-
项目类别:
-
资助金额:$9.29万
-
财政年份:1996
-
负责人:Deanna L Kroetz
-
依托单位:
PHARMACOLOGICAL EFFECTS OF CYTOCHROME P450 4A METABOLISM
-
批准号:6043838
-
项目类别:
-
资助金额:$9.55万
-
财政年份:1996
-
负责人:Deanna L Kroetz
-
依托单位:
CYTOCHROME P450 DEPENDENT ARACHIDONIC ACID METABOLISM
-
批准号:6637274
-
项目类别:
-
资助金额:$25.81万
-
财政年份:1996
-
负责人:Deanna L Kroetz
-
依托单位:
CYTOCHROME P450 DEPENDENT ARACHIDONIC ACID METABOLISM
-
批准号:6191514
-
项目类别:
-
资助金额:$28.31万
-
财政年份:1996
-
负责人:Deanna L Kroetz
-
依托单位:
PHARMACOLOGICAL EFFECTS OF CYTOCHROME P450 4A METABOLISM
-
批准号:2460109
-
项目类别:
-
资助金额:$9.62万
-
财政年份:1996
-
负责人:Deanna L Kroetz
-
依托单位:
CYTOCHROME P450 DEPENDENT ARACHIDONIC ACID METABOLISM
-
批准号:6526765
-
项目类别:
-
资助金额:$25.81万
-
财政年份:1996
-
负责人:Deanna L Kroetz
-
依托单位:
PHARMACOLOGICAL EFFECTS OF CYTOCHROME P450 4A METABOLISM
-
批准号:2232164
-
项目类别:
-
资助金额:$11.41万
-
财政年份:1996
-
负责人:Deanna L Kroetz
-
依托单位:
海外基金